Neurotropin was developed by Nippon Zoki Pharmaceutical Co. Ltd. It is produced by inoculating vaccine virus into rabbits and the effective substances are extracted from neuro-immuno inflamed cutaneous tissue. In the present study it was found that intraperitoneally administered neurotropin potently inhibits naloxone-precipitated withdrawal syndrome in morphine-dependent rats. Also we get the experimental evidence that neurotropin increases morphine action but has no positive-reinforcing properties. These data indicate the possibility of testing neurotropin as a medicine for treating opiate-abused patients.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
withdrawal syndrome
8
syndrome morphine-dependent
8
[neurotropin suppression
4
suppression manifestations
4
manifestations naloxone-provoked
4
naloxone-provoked withdrawal
4
morphine-dependent rats]
4
neurotropin
4
rats] neurotropin
4
neurotropin developed
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!